This analysis identified that 122 resulting probe sets of ARSN (VARS, QARS, CARS, NARS, FARS), DTGs (PDE4A, NF1, NBN, CETP, SMAD3, HIST3H2A, TFRC, PTPRC, MTAP, etc), and PPIs (PARD3, RXRB, ATP5C1, HSP90AA1, CD44, THRA, TRAF2, KRT10, MED12, etc) that were correlated with survival in patients with GBM (Table S5). Here, NF1 is linked to glioblastoma.